Prilenal 5 mg, Tablets Vereinigtes Königreich - Englisch - VMD (Veterinary Medicines Directorate)

prilenal 5 mg, tablets

ceva animal health ltd - enalapril maleate - tablet - cardio vascular ace inhibitor - dogs

Prilenal 1 mg, Tablets Vereinigtes Königreich - Englisch - VMD (Veterinary Medicines Directorate)

prilenal 1 mg, tablets

ceva animal health ltd - enalapril maleate - tablet - cardio vascular ace inhibitor - dogs

Prilenal 20 mg, Tablets Vereinigtes Königreich - Englisch - VMD (Veterinary Medicines Directorate)

prilenal 20 mg, tablets

ceva animal health ltd - enalapril maleate - tablet - cardio vascular ace inhibitor - dogs

Prilenal 10 mg, Tablets Vereinigtes Königreich - Englisch - VMD (Veterinary Medicines Directorate)

prilenal 10 mg, tablets

ceva animal health ltd - enalapril maleate - tablet - cardio vascular ace inhibitor - dogs

ISOPTIN verapamil hydrochloride 80mg tablet blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

isoptin verapamil hydrochloride 80mg tablet blister pack

viatris pty ltd - verapamil hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - immediate release tablets,isoptin is indicated for:,-hypertension,- angina of effort,- angina at rest,- vasospastic angina (including prinzmetal?s variant angina),- tachyarrhythmias including paroxysmal supra-ventricular tachycardia,- atrial fibrillation with rapid ventricular response,- atrial flutter with rapid ventricular response

ISOPTIN verapamil hydrochloride 40mg tablet blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

isoptin verapamil hydrochloride 40mg tablet blister pack

viatris pty ltd - verapamil hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - immediate release tablets,isoptin is indicated for:,-hypertension,- angina of effort,- angina at rest,- vasospastic angina (including prinzmetal?s variant angina),- tachyarrhythmias including paroxysmal supra-ventricular tachycardia,- atrial fibrillation with rapid ventricular response,- atrial flutter with rapid ventricular response

ISOPTIN 180SR verapamil hydrochloride 180mg tablet blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

isoptin 180sr verapamil hydrochloride 180mg tablet blister pack

viatris pty ltd - verapamil hydrochloride, quantity: 180 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; sodium alginate; povidone; magnesium stearate; hypromellose; macrogol 400; macrogol 6000; purified talc; glycol/butylene glycol montanate; titanium dioxide; iron oxide red - modified release tablets,isoptin sr is indicated for the management of hypertension and angina pectoris.

AMOXYCILLIN SANDOZ amoxicillin (as trihydrate) 1000 mg tablet blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

amoxycillin sandoz amoxicillin (as trihydrate) 1000 mg tablet blister pack

sandoz pty ltd - amoxicillin trihydrate, quantity: 1148 mg (equivalent: amoxicillin, qty 1000 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; sodium starch glycollate type a; hypromellose; titanium dioxide; purified talc - amoxycillin sandoz is indicated in the treatment of acute exacerbation of chronic bronchitis. notes: therapy should be guided by bacteriologic studies including sensitivity tests and by clinical response. amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative agent has yet to be identified. amoxycillin sandoz 1000mg tablets have not been shown to be bioequivalent to the 500mg and 250mg capsule formulations given in equivalent doses. therefore, amoxycillin sandoz 1000mg tablets and other forms of amoxycillin are not considered interchangeable. infections caused by pathogens with established penicllin g susceptibility should preferentially be treated with penicillin g.

ABACAVIR/LAMIVUDINE 600/300 APOTEX abacavir 600mg (as sulfate) and lamivudine 300mg tablets bottle Australien - Englisch - Department of Health (Therapeutic Goods Administration)

abacavir/lamivudine 600/300 apotex abacavir 600mg (as sulfate) and lamivudine 300mg tablets bottle

arrotex pharmaceuticals pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.76 mg (equivalent: abacavir, qty 600 mg) - tablet, film coated - excipient ingredients: hypromellose; titanium dioxide; sunset yellow fcf aluminium lake; macrogol 8000; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose - abacavir and lamivudine combination tablets are a combination of two nucleoside analogues (abacavir and lamivudine). ,abacavir and lamivudine combination tablets are indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Flecainide Sandoz flecainide acetate 100 mg tablet blister pack Australien - Englisch - Department of Health (Therapeutic Goods Administration)

flecainide sandoz flecainide acetate 100 mg tablet blister pack

boucher & muir pty ltd - flecainide acetate, quantity: 100 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; maize starch - 1. supraventricular arrhythmias: a) due to pre-excitation syndromes, e.g. wolff-parkinson-white and lown-ganong-levine syndromes. b) due to dual av nodal pathways in patients with debilitating symptoms. c) paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms.,although flecainide may be effective in supraventricular arrhythmias in patients with structural heart disease, its use has been associated with life-threatening and occasionally fatal ventricular arrhythmias. in these patients, particularly in the presence of impaired left ventricular function, flecainide should be used with extreme caution, preferably after other antiarrhythmic drugs have been tried or considered inappropriate.,use of flecainide in chronic atrial fibrillation has not been adequately studied and is not recommended.,2. life threatening ventricular arrhythmias not controlled by other drugs.,flecainide sandoz tablets are used for continuous maintenance of normal rhythm following initial oral or intravenous therapy or conversion by other means.,prescribers should also consult the "precautions" section of this product information.